The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved.

Ozempic and other semaglutide medications work by mimicking GLP-1—a natural hormone produced in the intestines that regulates ...

Two healthcare stocks in the white-hot weight-loss segment tanked on Monday as one of their rivals zoomed higher. The decliners were Novo Nordisk (NYSE: NVO), famously the company behind Wegovy, and ...

Ozempic, along with its sister drug Wegovy ... issued a medical product alert regarding falsified batches of semaglutide products, specifically Ozempic, detected in Brazil, the UK, and the ...

Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.

"Adherence improves when treatment integrates easily into patients’ lives," explains Adam McBride, Eden’s CEO. Eden’s digital ...

And last year, the FDA issued warnings about the drugs, but they haven’t been recalled and remain readily available. So, what is going on with compounded semaglutide, and is it safe? How can you tell ...

Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...

And last year, the FDA issued warnings about the drugs, but they haven’t been recalled and remain readily available. So, what is going on with compounded semaglutide, and is it safe? How can you ...